Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.

Trepanier M, Paradis T, Kouyoumdjian A, Dumitra T, Charlebois P, Stein BS, Liberman AS, Schwartzman K, Carli F, Fried GM, Feldman LS, Lee L.

J Gastrointest Surg. 2019 Jul 31. doi: 10.1007/s11605-019-04328-4. [Epub ahead of print]

PMID:
31367895
2.

Improved Disease-free Survival After Prehabilitation for Colorectal Cancer Surgery.

Trépanier M, Minnella EM, Paradis T, Awasthi R, Kaneva P, Schwartzman K, Carli F, Fried GM, Feldman LS, Lee L.

Ann Surg. 2019 Sep;270(3):493-501. doi: 10.1097/SLA.0000000000003465.

PMID:
31318793
3.

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.

Campbell JR, Dowdy D, Schwartzman K.

PLoS Med. 2019 Jun 6;16(6):e1002824. doi: 10.1371/journal.pmed.1002824. eCollection 2019 Jun.

4.

Estimated impact of World Health Organization latent tuberculosis screening guidelines in a low TB incidence region: retrospective cohort study.

Ronald LA, Campbell JR, Rose C, Balshaw R, Romanowski K, Roth D, Marra F, Schwartzman K, Cook VJ, Johnston JC.

Clin Infect Dis. 2019 Mar 11. pii: ciz188. doi: 10.1093/cid/ciz188. [Epub ahead of print]

PMID:
30856258
5.

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities.

N'Diaye DS, Nsengiyumva NP, Uppal A, Oxlade O, Alvarez GG, Schwartzman K.

BMC Med. 2019 Feb 4;17(1):26. doi: 10.1186/s12916-019-1261-5.

6.

Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review.

Cormier M, Schwartzman K, N'Diaye DS, Boone CE, Dos Santos AM, Gaspar J, Cazabon D, Ghiasi M, Kahn R, Uppal A, Morris M, Oxlade O.

Lancet Glob Health. 2019 Jan;7(1):e68-e80. doi: 10.1016/S2214-109X(18)30435-2. Erratum in: Lancet Glob Health. 2019 Mar 4;:.

7.

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support.

Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, Bastos M, Trajman A, Falzon D, Schwartzman K.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801363. doi: 10.1183/13993003.01363-2018. Print 2018 Nov.

8.

You pay for what you get: the true cost of tuberculosis.

Schwartzman K.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):969. doi: 10.5588/ijtld.18.0416. No abstract available.

PMID:
30092858
9.

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Obeng Baah J, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata RC, Kritski A, Rolla V, Bah B, Camara A, Boakye I, Cook VJ, Goldberg H, Valiquette C, Hornby K, Dion MJ, Li PZ, Hill PC, Schwartzman K, Benedetti A.

N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.

10.

Safety and Side Effects of Rifampin versus Isoniazid in Children.

Diallo T, Adjobimey M, Ruslami R, Trajman A, Sow O, Obeng Baah J, Marks GB, Long R, Elwood K, Zielinski D, Gninafon M, Wulandari DA, Apriani L, Valiquette C, Fregonese F, Hornby K, Li PZ, Hill PC, Schwartzman K, Benedetti A, Menzies D.

N Engl J Med. 2018 Aug 2;379(5):454-463. doi: 10.1056/NEJMoa1714284.

11.

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.

Caron M, Hoa S, Hudson M, Schwartzman K, Steele R.

Eur Respir Rev. 2018 May 15;27(148). pii: 170102. doi: 10.1183/16000617.0102-2017. Print 2018 Jun 30. Review.

12.

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.

Moro RN, Scott NA, Vernon A, Tepper NK, Goldberg SV, Schwartzman K, Leung CC, Schluger NW, Belknap RW, Chaisson RE, Narita M, Machado ES, Lopez M, Sanchez J, Villarino ME, Sterling TR.

Ann Am Thorac Soc. 2018 May;15(5):570-580. doi: 10.1513/AnnalsATS.201704-326OC.

13.

The impact of digital health technologies on tuberculosis treatment: a systematic review.

Ngwatu BK, Nsengiyumva NP, Oxlade O, Mappin-Kasirer B, Nguyen NL, Jaramillo E, Falzon D, Schwartzman K; Collaborative group on the impact of digital technologies on TB.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701596. doi: 10.1183/13993003.01596-2017. Print 2018 Jan.

14.

Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.

Ezer N, Navasakulpong A, Schwartzman K, Ofiara L, Gonzalez AV.

BMC Pulm Med. 2017 Dec 8;17(1):178. doi: 10.1186/s12890-017-0504-5.

15.

Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.

Mullie GA, Schwartzman K, Zwerling A, N'Diaye DS.

BMC Med. 2017 May 17;15(1):104. doi: 10.1186/s12916-017-0865-x.

16.

Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.

Ronald LA, Ling DI, FitzGerald JM, Schwartzman K, Bartlett-Esquilant G, Boivin JF, Benedetti A, Menzies D.

Int J Tuberc Lung Dis. 2017 May 1;21(5):517-522. doi: 10.5588/ijtld.16.0588. Review.

PMID:
28399966
17.

Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study.

Ronald LA, FitzGerald JM, Benedetti A, Boivin JF, Schwartzman K, Bartlett-Esquilant G, Menzies D.

BMC Infect Dis. 2016 Nov 15;16(1):679.

18.

Latent Tuberculosis in Pregnancy: A Systematic Review.

Malhamé I, Cormier M, Sugarman J, Schwartzman K.

PLoS One. 2016 May 5;11(5):e0154825. doi: 10.1371/journal.pone.0154825. eCollection 2016. Review.

19.

Maternal sleep-disordered breathing and the risk of delivering small for gestational age infants: a prospective cohort study.

Pamidi S, Marc I, Simoneau G, Lavigne L, Olha A, Benedetti A, Sériès F, Fraser W, Audibert F, Bujold E, Gagnon R, Schwartzman K, Kimoff RJ.

Thorax. 2016 Aug;71(8):719-25. doi: 10.1136/thoraxjnl-2015-208038. Epub 2016 Apr 15.

PMID:
27084956
20.

Xpert®MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation.

Oxlade O, Sugarman J, Alvarez GG, Pai M, Schwartzman K.

PLoS One. 2016 Mar 18;11(3):e0150119. doi: 10.1371/journal.pone.0150119. eCollection 2016.

21.

Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project.

Adachi N, Adamovitch V, Adjovi Y, Aida K, Akamatsu H, Akiyama S, Akli A, Ando A, Andrault T, Antonietti H, Anzai S, Arkoun G, Avenoso C, Ayrault D, Banasiewicz M, Banaśkiewicz M, Bernardini L, Bernard E, Berthet E, Blanchard M, Boreyko D, Boros K, Charron S, Cornette P, Czerkas K, Dameron M, Date I, De Pontbriand M, Demangeau F, Dobaczewski Ł, Dobrzyński L, Ducouret A, Dziedzic M, Ecalle A, Edon V, Endo K, Endo T, Endo Y, Etryk D, Fabiszewska M, Fang S, Fauchier D, Felici F, Fujiwara Y, Gardais C, Gaul W, Gurin L, Hakoda R, Hamamatsu I, Handa K, Haneda H, Hara T, Hashimoto M, Hashimoto T, Hashimoto K, Hata D, Hattori M, Hayano R, Hayashi R, Higasi H, Hiruta M, Honda A, Horikawa Y, Horiuchi H, Hozumi Y, Ide M, Ihara S, Ikoma T, Inohara Y, Itazu M, Ito A, Janvrin J, Jout I, Kanda H, Kanemori G, Kanno M, Kanomata N, Kato T, Kato S, Katsu J, Kawasaki Y, Kikuchi K, Kilian P, Kimura N, Kiya M, Klepuszewski M, Kluchnikov E, Kodama Y, Kokubun R, Konishi F, Konno A, Kontsevoy V, Koori A, Koutaka A, Kowol A, Koyama Y, Kozioł M, Kozue M, Kravtchenko O, Kruczała W, Kudła M, Kudo H, Kumagai R, Kurogome K, Kurosu A, Kuse M, Lacombe A, Lefaillet E, Magara M, Malinowska J, Malinowski M, Maroselli V, Masui Y, Matsukawa K, Matsuya K, Matusik B, Maulny M, Mazur P, Miyake C, Miyamoto Y, Miyata K, Miyata K, Miyazaki M, Molȩda M, Morioka T, Morita E, Muto K, Nadamoto H, Nadzikiewicz M, Nagashima K, Nakade M, Nakayama C, Nakazawa H, Nihei Y, Nikul R, Niwa S, Niwa O, Nogi M, Nomura K, Ogata D, Ohguchi H, Ohno J, Okabe M, Okada M, Okada Y, Omi N, Onodera H, Onodera K, Ooki S, Oonishi K, Oonuma H, Ooshima H, Oouchi H, Orsucci M, Paoli M, Penaud M, Perdrisot C, Petit M, Piskowski A, Płocharski A, Polis A, Polti L, Potsepnia T, Przybylski D, Pytel M, Quillet W, Remy A, Robert C, Sadowski M, Saito M, Sakuma D, Sano K, Sasaki Y, Sato N, Schneider T, Schneider C, Schwartzman K, Selivanov E, Sezaki M, Shiroishi K, Shustava I, Śniecińska A, Stalchenko E, Staroń A, Stromboni M, Studzińska W, Sugisaki H, Sukegawa T, Sumida M, Suzuki Y, Suzuki K, Suzuki R, Suzuki H, Suzuki K, Świderski W, Szudejko M, Szymaszek M, Tada J, Taguchi H, Takahashi K, Tanaka D, Tanaka G, Tanaka S, Tanino K, Tazbir K, Tcesnokova N, Tgawa N, Toda N, Tsuchiya H, Tsukamoto H, Tsushima T, Tsutsumi K, Umemura H, Uno M, Usui A, Utsumi H, Vaucelle M, Wada Y, Watanabe K, Watanabe S, Watase K, Witkowski M, Yamaki T, Yamamoto J, Yamamoto T, Yamashita M, Yanai M, Yasuda K, Yoshida Y, Yoshida A, Yoshimura K, Żmijewska M, Zuclarelli E.

J Radiol Prot. 2016 Mar;36(1):49-66. doi: 10.1088/0952-4746/36/1/49. Epub 2015 Nov 27.

PMID:
26613195
22.

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.

23.

Health-related quality of life and tuberculosis: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Health Qual Life Outcomes. 2015 May 27;13:65. doi: 10.1186/s12955-015-0250-4.

24.

Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.

Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB.

HIV Clin Trials. 2015 May-Jun;16(3):100-10. doi: 10.1179/501100000024. Epub 2015 May 14.

PMID:
25972048
25.

Respiratory medicine and research at McGill University: a historical perspective.

Martin J, Schwartzman K.

Can Respir J. 2015 Jan-Feb;22(1):18-9. No abstract available.

26.

Towards probabilistic decision support in public health practice: predicting recent transmission of tuberculosis from patient attributes.

Mamiya H, Schwartzman K, Verma A, Jauvin C, Behr M, Buckeridge D.

J Biomed Inform. 2015 Feb;53:237-42. doi: 10.1016/j.jbi.2014.11.006. Epub 2014 Nov 20.

27.

The impact of tuberculosis on health utility: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Qual Life Res. 2015 Jun;24(6):1337-49. doi: 10.1007/s11136-014-0858-6. Epub 2014 Nov 13.

PMID:
25391490
28.

Sputum induction for tuberculosis diagnosis in an Arctic setting: a cost comparison.

Sugarman J, Alvarez GG, Schwartzman K, Oxlade O.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1223-30. doi: 10.5588/ijtld.14.0163.

PMID:
25216837
29.

Accuracy of prospective space-time surveillance in detecting tuberculosis transmission.

Verma A, Schwartzman K, Behr MA, Zwerling A, Allard R, Rochefort CM, Buckeridge DL.

Spat Spatiotemporal Epidemiol. 2014 Apr;8:47-54. doi: 10.1016/j.sste.2014.01.003. Epub 2014 Jan 23.

PMID:
24606994
30.

Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.

Ditkowsky JB, Schwartzman K.

PLoS One. 2014 Jan 15;9(1):e83526. doi: 10.1371/journal.pone.0083526. eCollection 2014.

31.

Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact.

Sohn H, Aero AD, Menzies D, Behr M, Schwartzman K, Alvarez GG, Dan A, McIntosh F, Pai M, Denkinger CM.

Clin Infect Dis. 2014 Apr;58(7):970-6. doi: 10.1093/cid/ciu022. Epub 2014 Jan 14.

PMID:
24429440
32.

Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.

Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C.

PLoS One. 2013 Oct 18;8(10):e78548. doi: 10.1371/journal.pone.0078548. eCollection 2013.

33.

Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.

Greenaway C, Boivin JF, Cnossen S, Rossi C, Tapiero B, Schwartzman K, Olson S, Miller M.

Epidemiol Infect. 2014 Aug;142(8):1695-707. doi: 10.1017/S0950268813002768. Epub 2013 Nov 1.

PMID:
24176291
34.

The eye of the beholder: tuberculosis screening for elderly long-term care residents.

Schwartzman K, Dowdy D.

Int J Tuberc Lung Dis. 2013 Sep;17(9):1121. doi: 10.5588/ijtld.13.0496. No abstract available.

PMID:
23928162
35.

Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis.

Pamidi S, Pinto LM, Marc I, Benedetti A, Schwartzman K, Kimoff RJ.

Am J Obstet Gynecol. 2014 Jan;210(1):52.e1-52.e14. doi: 10.1016/j.ajog.2013.07.033. Epub 2013 Aug 2. Review.

PMID:
23911687
36.

Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India.

Zwerling A, Joshi R, Kalantri SP, Dakshinamoorthy G, Reddy MV, Benedetti A, Schwartzman K, Menzies D, Pai M.

J Epidemiol Glob Health. 2013 Jun;3(2):105-17. doi: 10.1016/j.jegh.2013.03.003. Epub 2013 Apr 10.

37.

Tuberculosis vaccine trials.

Behr MA, Schwartzman K, Pai M.

Lancet. 2013 Jun 29;381(9885):2252-3. doi: 10.1016/S0140-6736(13)61481-6. No abstract available.

PMID:
23809560
38.

The association of the distance walked in 6 min with pre-operative peak oxygen consumption and complications 1 month after colorectal resection.

Lee L, Schwartzman K, Carli F, Zavorsky GS, Li C, Charlebois P, Stein B, Liberman AS, Fried GM, Feldman LS.

Anaesthesia. 2013 Aug;68(8):811-6. doi: 10.1111/anae.12329. Epub 2013 Jun 21.

39.

Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance.

Law S, Benedetti A, Oxlade O, Schwartzman K, Menzies D.

Eur Respir J. 2014 Feb;43(2):566-81. doi: 10.1183/09031936.00005613. Epub 2013 Jun 13.

40.

Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?

Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Menzies D, Pai M.

PLoS One. 2013;8(1):e54748. doi: 10.1371/journal.pone.0054748. Epub 2013 Jan 31.

41.

Development of a simple reliable radiographic scoring system to aid the diagnosis of pulmonary tuberculosis.

Pinto LM, Dheda K, Theron G, Allwood B, Calligaro G, van Zyl-Smit R, Peter J, Schwartzman K, Menzies D, Bateman E, Pai M, Dawson R.

PLoS One. 2013;8(1):e54235. doi: 10.1371/journal.pone.0054235. Epub 2013 Jan 18.

42.

A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life.

Bauer M, Leavens A, Schwartzman K.

Qual Life Res. 2013 Oct;22(8):2213-35. doi: 10.1007/s11136-012-0329-x. Epub 2012 Dec 12. Review.

43.

Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review.

Pinto LM, Pai M, Dheda K, Schwartzman K, Menzies D, Steingart KR.

Eur Respir J. 2013 Aug;42(2):480-94. doi: 10.1183/09031936.00107412. Epub 2012 Dec 6. Review.

44.

Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.

Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C.

PLoS One. 2012;7(9):e44611. doi: 10.1371/journal.pone.0044611. Epub 2012 Sep 5. Review.

45.

TB screening in Canadian health care workers using interferon-gamma release assays.

Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M.

PLoS One. 2012;7(8):e43014. doi: 10.1371/journal.pone.0043014. Epub 2012 Aug 20.

46.

Health care utilization by preterm infants with respiratory complications in Quebec.

Landry JS, Croitoru D, Jin Y, Schwartzman K, Benedetti A, Menzies D.

Can Respir J. 2012 Jul-Aug;19(4):255-60.

47.

Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.

Ling DI, Crépeau CA, Dufresne M, Khan S, Quach C, Dendukuri N, Schwartzman K, Menzies D, Lands LC, Pai M.

Pediatr Infect Dis J. 2012 Dec;31(12):1258-62. doi: 10.1097/INF.0b013e318269d10c.

PMID:
22828646
48.

Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis.

Smith BM, Pinto L, Ezer N, Sverzellati N, Muro S, Schwartzman K.

Lung Cancer. 2012 Jul;77(1):58-63. doi: 10.1016/j.lungcan.2012.02.019. Epub 2012 Mar 20. Review.

PMID:
22437042
49.

Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials.

Esfahani K, Aspler A, Menzies D, Schwartzman K.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1340-6. doi: 10.5588/ijtld.10.0575.

PMID:
22283892
50.

Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis.

Trojan DA, Kaminska M, Bar-Or A, Benedetti A, Lapierre Y, Da Costa D, Robinson A, Cardoso M, Schwartzman K, Kimoff RJ.

J Neurol Sci. 2012 May 15;316(1-2):158-63. doi: 10.1016/j.jns.2011.12.013. Epub 2012 Jan 16.

PMID:
22251932

Supplemental Content

Loading ...
Support Center